Masahito Ohji et al <br/><br/>
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works